Drug intelligence / Profile preview

N-acetyl cysteine + alpha lipoic acid + liposomal glutathione (Merz)

Development stage
Discontinued
Lead developer
Merz North America
Modality
Small Molecules
Administration
Topical
01

Overview

N-acetyl cysteine (NAC), alpha lipoic acid (ALA), and liposomal glutathione represent a combination of potent antioxidant compounds intended to enhance cellular defense against oxidative stress and inflammation. N-acetyl cysteine serves as a precursor for the synthesis of glutathione, the body's primary endogenous antioxidant. Alpha lipoic acid is a versatile dithiol compound that can scavenge free radicals and regenerate other antioxidants like vitamins C and E. Liposomal glutathione provides a direct, encapsulated form of the tripeptide to improve systemic bioavailability. This combination has been explored for its potential to mitigate oxidative stress-induced damage in dermatological conditions such as atopic dermatitis. However, it is important to note that the specific Phase 3 clinical trial context often associated with Merz North America in atopic dermatitis (MSRD-100) specifically evaluates desoximetasone, a topical corticosteroid, rather than this antioxidant mixture, suggesting a discrepancy between the drug name and the clinical trial context provided.

Brand names
Auro GSH
Other names
NAC + ALA + GlutathioneAntioxidant Protocol
02

Targets

GSH (Glutathione)

Beyond the preview

Go deeper on N-acetyl cysteine + alpha lipoic acid + liposomal glutathione (Merz).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-acetyl cysteine + alpha lipoic acid + liposomal glutathione (Merz).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call